KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target

21 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Explore the multifaceted role of KRT17 in cancer, from its involvement in tumor initiation and progression to its emerging significance as a therapeutic target. This video delves into the molecular mechanisms by which KRT17 promotes resistance to conventional chemotherapeutics and targeted agents, highlighting its potential as a valuable therapeutic target. We will also discuss the challenges and opportunities in developing strategies to therapeutically exploit this critical molecule.
Categoria
Oncology
Commenta per primo questo video.

Prossimo